Right now with AMRN I am watching the last price 2.11 High 2.13 Low 2.00 Change +0.14 and percent change +7.11%
Do you have any opinions about AMRN stock? Share them with me. I would like to know.
AMRN Amarin Corp Ads
Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...
Continue Reading
The world of ocean energy just got a jolt from an unlikely corner. Minesto, the ocean energy whiz, and Morteza Capital, a savvy investment force entrenched in the Maldives, are shaking hands to usher tidal energy into this paradise. Tidal Waves Meet Tourism When you're talking about the Maldives, you're talking about two main things: pristine tropical getaways and a whole...
Continue Reading
Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...
Continue Reading
Spokane Forum Sparks Action for Veterans' Policies Gonzaga University turned into a powerhouse of dialogue and determination as the Wounded Warrior Project (WWP) gathered over 145 veterans, elected officials, and advocate groups to hash out critical policy priorities. We're talking high-stakes discussions with real consequences, not just some feel-good meet-up. A...
Continue Reading
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue Reading
A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...
Continue Reading
Time for a Change The head of the World Water Council, Loïc Fauchon, didn't mince words at the 9th Cairo Water Week. He proclaimed the old methods of water management are sinking under a flood of modern challenges. Toss in climate upheavals, ballooning cities, and unpredictable diets, and you've got yourself a swirling mess that traditional strategies just can’t mop...
Continue Reading
UFP Industries Makes a Strategic Move Folks, it looks like UFP Industries (NASDAQ: UFPI) is making some solid moves down in the Gulf Coast, and they're shelling out $27 million to do it. This time, they've got their eyes on Apache Products, dba Acme Skid, a company that's been doing the heavy lifting in the pallet manufacturing space in Silsbee, Texas. Apparently, these...
Continue Reading
Dalrymple's Short Report Shakes Csquare's Core Csquare, Inc. (NYSE: CSQR) is reeling from a one-two punch: a damning short report by Dalrymple Finance and an 11.8% share tumble. The timing of this financial body blow, coinciding with Csquare's discordant cash flow claims, could mark the beginning of a long battle for investor trust. This ain't the first time the markets...
Continue Reading
Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...
Continue Reading
Current Performance of Johnson & Johnson Stock Johnson & Johnson (NYSE: JNJ) has made a significant impression this year, with the stock soaring nearly 42.9% to date. This impressive growth includes a rise of about 35% over the past six months and an 8.6% uptick in just the past month. Investors are keen to know what’s driving this positive trend. Recent Earnings Report...
Continue Reading
Thombar Launches to Support Specialty Crop Growers A new banking platform is designed specifically for the unique needs of U.S. specialty crop growers. Introducing Thombar, a pioneering financial technology company that has just launched a new banking platform aimed at empowering specialty crop growers across the nation. Specializing in the diverse agricultural landscape,...
Continue Reading
Understanding the Current Legal Situation for Snap Inc. The Gross Law Firm has issued an important notice that could impact numerous shareholders of Snap Inc. (NYSE: SNAP). As part of an ongoing class action lawsuit, those who purchased SNAP shares during the specified class period are encouraged to seek guidance on potential legal recourse. Who Should Consider...
Continue Reading
Alfa|SIGMA Reports Strong Results for 1Q25 Alfa, S.A.B. de C.V. has unveiled its financial accomplishments for the first quarter of 2025, showcasing a significant EBITDA of $220 million. This remarkable performance indicates the company's steady trajectory toward achieving its ambitious target of $1 billion for the full year. Highlights of 1Q25 Performance Transformative...
Continue Reading
Unveiling the A-688 Rotary Stage for Precise Motion Control The A-688 rotary stage, crafted by PI, represents an evolution in precision motion control solutions. This innovative product is designed to offer maintenance-free performance along with ultra-high resolution and high-speed capabilities. Frictionless Design for Superior Performance Engineered with a unique...
Continue Reading